Published on 24 Apr 2024 on Simply Wall St. via Yahoo Finance
With the business potentially at an important milestone, we thought we'd take a closer look at Liquidia Corporation's (NASDAQ:LQDA) future prospects. Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. The US$985m market-cap company announced a latest loss of US$79m on 31 December 2023 for its most recent financial year result. The most pressing concern for investors is Liquidia's path to profitability – when will it breakeven? Below we will provide a high-level summary of the industry analysts’ expectations for the company.
Check out our latest analysis for Liquidia